xRead - September 2022

Wise et al.

Page 316

Author Manuscript Author Manuscript Author Manuscript Author Manuscript

Study Year LOE Study design Study groups Clinical endpoint Conclusion Bukstein et al. 688 2016 3b Observational cohort cross-sectional

Beclomethasone improves QOL, school-related activities, satisfaction, productivity, and sleep quality.

Middle school students, cross-sectional stratified random sampling (n = 814) Questionnaire AR in 17.2%. AR impacts QOL, sleep, emotions, and memory. AR (n = 303) Questionnaire AR impacts work/school performance, general QOL, and sleep quality.

PAR treated with beclomethasone (n = 527) RCAT, treatment satisfaction, WPAI, PSQI, mini-RQLQ

cross-sectional

Song et al. 685 2015 3b Observational

Katelaris et al. 687 2013 3b Observational

15D = Generic 15 Dimension Instrument for measuring health related quality of life; AR = allergic rhinitis; DM = diabetes mellitus; HRQOL = Health-Related Quality of Life; LOE = level of evidence; MOS-12 Sleep = Medical Outcomes Study 12-Item Sleep Scale; PANAS-X = Positive and Negative Affect Schedule-Expanded Form; PAR = perennial allergic rhinitis; PSQI = Pittsburgh Sleep Quality Index; QOL = quality of life; RCAT = Rhinitis Control Assessment Test; RCT = randomized controlled trial; RQL = rhinitis quality of life; RQLQ = rhino-conjunctivitis quality of life questionnaire; SAR = seasonal allergic rhinitis; SAT-P = satisfaction profile; SCIT = subcutaneous immunotherapy; SF-12 = short form 12; SF-36 = short form 36; SLIT = sublingual immunotherapy; SR; systematic review; TSS = total symptom score; VAS = visual analogue scale; WPAI = Work Productivity and Activity questionnaire; WPAIAS = Work Productivity and Activity Allergy Specific questionnaire.

Int Forum Allergy Rhinol . Author manuscript; available in PMC 2020 June 10.